#United States #New York #biotechnology #Onassis Holdings #Paz Itzhaki-Weinberger

Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger

On November 5, 2025, Onassis Holding Corp, a leading U.S. biotechnology firm specializing in cellular rejuvenation and longevity solutions, announced a significant addition to its Advisory Board. The company has appointed Esq. Paz Itzhaki-Weinberger, an esteemed expert in technology, law, and international business. This strategic move aims to enhance the firm’s focus on international law, trade, and cross-border corporate affairs.

Who is Paz Itzhaki-Weinberger?

Paz Itzhaki-Weinberger is known for his profound expertise that melds the worlds of engineering and law. His journey includes notable leadership roles at Microsoft Corporation and various high-tech ventures, which provide him with a unique perspective on the intersection of law and technology in today's business landscape. Holding a blend of degrees in Computer Science and Law, he has a versatile professional background that prepares him well for his new role.

Previously, Itzhaki-Weinberger led PatentsFund.com, where he provided valuable insights to technology firms regarding Initial Public Offerings (IPOs) and mergers and acquisitions (M&As). His vast experience is further complemented by his proficiency in multiple languages, including English, Hebrew, Japanese, German, and Arabic, making him a valuable asset in international negotiations and collaborations.

Itzhaki-Weinberger's legal career is marked by his practice at one of Israel's top law firms and the founding of PIWLAW, which has been recognized among the world's top law firms from 2014 to 2025 by Legals Finest. He also holds memberships in several prestigious organizations, such as the Israel Bar Association, the American Bar Association's International Law Division, and The Law Society of England and Wales. He is an active Senior Member of IEEE and serves on the board of the Israel-Britain Chamber of Commerce.

The Role of the Advisory Board

In his capacity on the Advisory Board of Onassis Holdings Corp, Itzhaki-Weinberger will lead initiatives that relate to international legal frameworks and trade agreements crucial for biotechnology enterprises. The company is firm in its commitment to harmonizing regulatory affairs across borders to accelerate its innovative locale in regenerative medicine. His insights are expected to drive Onassis Holdings forward in navigating the complex legalities associated with international markets.

Onassis Holdings is uniquely positioned as a pioneer in biotechnology, specifically focusing on innovations that enhance cellular rejuvenation processes aimed at longevity. By leveraging strategic partnerships and cutting-edge research, the company aspires to introduce groundbreaking regenerative medicine solutions to the global market. With Itzhaki-Weinberger now contributing to the firm’s vision, there is confidence that Onassis will strengthen its global presence and streamline operations throughout its international dealings.

This appointment not only reflects Onassis Holdings' ambitious plans but also emphasizes its dedication to achieving excellence in operational governance. As the company progresses, the role of experts like Itzhaki-Weinberger will be invaluable in steering the course of biotechnology advancements governed by robust legal standards.

A Bright Future Ahead

With significant advancements underway at Onassis Holdings, the future seems bright for innovations that could potentially redefine longevity and restorative health. Under the guidance of experienced leaders like Esq. Paz Itzhaki-Weinberger, Onassis Holdings is well-prepared to tackle the complexities of international law and trade, ultimately enhancing its contributions to the global healthcare ecosystem.

In summary, the addition of Itzhaki-Weinberger to the Advisory Board signifies a strategic enhancement of Onassis Holdings' capabilities, ensuring a comprehensive approach to navigating the intricate landscape of international law in the biotechnology sector.